Who founded Vima Therapeutics, Inc.?

Vima Therapeutics, Inc. was founded by Bernard Ravina.

Who are Vima Therapeutics, Inc.'s investors?

Vima Therapeutics, Inc.'s investors include Atlas Venture, Frazier Life Sciences, Access Industries, Access Biotechnology, Canaan Partners.

Vima Therapeutics, Inc.

26 employees on LinkedIn · 5 known investors

Find your way into Vima Therapeutics, Inc.

Paths you didn't know you had: your email and LinkedIn already hold routes to the Vima Therapeutics, Inc. team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vima Therapeutics is a biotech company developing drug treatments for movement disorders such as dystonia and related neurological diseases. It is run by a team of physicians, scientists, and drug-development specialists focused on neurological conditions.

Biotech Healthtech Medical Devices

Founders & leadership

Bernard RavinaFounder and Chief Executive Officer

Judy DunnPresident of Research & Development

Jessica FeesChief Financial Officer

Ariel D. JasieChief Business Officer and General CounselAriel D. Jasie is Chief Business Officer and General Counsel at Vima Therapeutics, a biotech company developing treatments for movement and neurological disorders.

Tushar MisraChief Technical OfficerTushar Misra is Chief Technical Officer at Vima Therapeutics. He brings over 20 years of pharmaceutical development and manufacturing experience, including roles at Mersana, Wave Life Sciences, Takeda, and Sunovion focused on small-molecule, biologic, and oligonucleotide products across clinical development, scale-up, and commercial operations.

Investors · 5

Atlas Venture✓ confirmed by Vima Therapeutics, Inc.Cambridge · $500K – $1M

How we know: Atlas Venture's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Frazier Life Sciences✓ confirmed by Vima Therapeutics, Inc.Palo Alto

How we know: the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us

Access Industries✓ confirmed by Vima Therapeutics, Inc.New York

How we know: the company's own site · Not right? Tell us

Access Biotechnologylisted by Access BiotechnologyNew York

How we know: Access Biotechnology's portfolio page · Not right? Tell us

Canaan Partnerslisted by Canaan PartnersStamford · $500K – $20M

How we know: Canaan Partners's portfolio page · Not right? Tell us

Frequently asked questions

What does Vima Therapeutics, Inc. do?: Vima Therapeutics is a biotech company developing drug treatments for movement disorders such as dystonia and related neurological diseases. It is run by a team of physicians, scientists, and drug-development specialists focused on neurological conditions.
Who founded Vima Therapeutics, Inc.?: Vima Therapeutics, Inc. was founded by Bernard Ravina.
Who are Vima Therapeutics, Inc.'s investors?: Vima Therapeutics, Inc.'s investors include Atlas Venture, Frazier Life Sciences, Access Industries, Access Biotechnology, Canaan Partners.